Back to Search
Start Over
Imaging biomarker roadmap for cancer studies
- Source :
- Nature Reviews Clinical Oncology; March 2017, Vol. 14 Issue: 3 p169-186, 18p
- Publication Year :
- 2017
-
Abstract
- Imaging biomarkers (IBs) are used extensively in drug development and cancer research, but important differences exist between IBs and biospecimen-derived biomarkers. A tailored 'roadmap' is required for the development of new IBs to be used either in clinical research or for decision-making in healthcare. In this Consensus statement, a group of experts assembled by CRUK and the EORTC present 14 key recommendations for accelerating the clinical translation of IBs.
Details
- Language :
- English
- ISSN :
- 17594774 and 17594782
- Volume :
- 14
- Issue :
- 3
- Database :
- Supplemental Index
- Journal :
- Nature Reviews Clinical Oncology
- Publication Type :
- Periodical
- Accession number :
- ejs41360969
- Full Text :
- https://doi.org/10.1038/nrclinonc.2016.162